Live News EQUITY FLASH L impact Oct 10, 2026, 09:42 PM UTC Roche Presents New Phase Iii One-Year Data For Vamikibart In Uveitic Macular Edema Roche Holding AG BX:RHO RHO SquawkNews Desk